Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.
about
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy.Prescribing efficiency of proton pump inhibitors in China: influence and future directionsEffects of drug price reduction and prescribing restrictions on expenditures and utilisation of antihypertensive drugs in Korea.Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FuturePersistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history.Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature.Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage.Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa.Policies for biosimilar uptake in Europe: An overview.Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications.Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme.Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications.
P2860
Q30978981-642C88B8-8C18-4616-96A3-64275ADDB41CQ35021173-5E4C2773-119C-449B-B4AF-22B23D3F4E78Q35884906-5BAD8747-2BFB-4777-83D2-0085557C50C3Q37135584-066C599E-09F6-4F74-AF89-B52D6FADAF43Q37328828-D8183C57-C50E-4EA2-859B-3BD495D8EB4EQ38263092-7B8AEB64-35A2-4ABB-93A9-614876204F94Q38285316-BBEF2F3E-5BD4-4055-8CFD-F224DECC5D39Q38392582-301F740B-ABD7-48AB-8F7E-7D45D2D39C0EQ38655036-566790E7-320B-411B-9616-6C9526D8A1EFQ40792327-BE19C06F-630C-4673-9DED-92BF3D242BBAQ47173303-B07A9CC1-5E32-4C2E-B011-7CDA7B9A0C81Q47292963-B5B3C83C-FC21-4BBA-8384-0A8A20C27728Q48505941-C3F3FADB-7174-4225-96B5-145330F88FB4Q51297152-6765ECE3-972A-4D39-A83B-E89F6E9CC4D2Q55078654-4E3DB009-A346-4B9A-BDC2-0F0148239B3D
P2860
Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Different initiatives across E ...... rics: impact and implications.
@ast
Different initiatives across E ...... rics: impact and implications.
@en
Different initiatives across E ...... rics: impact and implications.
@nl
type
label
Different initiatives across E ...... rics: impact and implications.
@ast
Different initiatives across E ...... rics: impact and implications.
@en
Different initiatives across E ...... rics: impact and implications.
@nl
prefLabel
Different initiatives across E ...... rics: impact and implications.
@ast
Different initiatives across E ...... rics: impact and implications.
@en
Different initiatives across E ...... rics: impact and implications.
@nl
P2093
P2860
P50
P356
P1476
Different initiatives across E ...... rics: impact and implications.
@en
P2093
Andrew Martin
Anna Bucsics
Corinne Zara
Iain Bishop
Max Petzold
Rickard E Malmström
Samantha Alvarez-Madrazo
Steven Simoens
Ulrik Hesse
P2860
P356
10.3389/FPHAR.2014.00219
P577
2014-10-08T00:00:00Z